We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ABSI

Price
2.79
Stock movement up
+0.04 (1.45%)
Company name
Absci Corp
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
417.17M
Ent value
412.87M
Price/Sales
99.16
Price/Book
2.07
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-18.18%
3 year return
-5.63%
5 year return
-
10 year return
-
Last updated: 2025-08-27

DIVIDENDS

ABSI does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales99.16
Price to Book2.07
EV to Sales98.14

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count149.52M
EPS (TTM)-0.86
FCF per share (TTM)-0.62

Income statement

Loading...
Income statement data
Revenue (TTM)4.21M
Gross profit (TTM)-6.08M
Operating income (TTM)-103.35M
Net income (TTM)-97.67M
EPS (TTM)-0.86
EPS (1y forward)-0.65

Margins

Loading...
Margins data
Gross margin (TTM)-144.45%
Operating margin (TTM)-2456.69%
Profit margin (TTM)-2321.56%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash38.20M
Net receivables1.50M
Total current assets150.14M
Goodwill0.00
Intangible assets45.73M
Property, plant and equipment0.00
Total assets235.23M
Accounts payable1.67M
Short/Current long term debt11.99M
Total current liabilities26.69M
Total liabilities33.90M
Shareholder's equity201.34M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-70.36M
Capital expenditures (TTM)398.00K
Free cash flow (TTM)-70.76M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-48.51%
Return on Assets-41.52%
Return on Invested Capital-47.34%
Cash Return on Invested Capital-34.29%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open2.98
Daily high3.03
Daily low2.76
Daily Volume9.80M
All-time high30.29
1y analyst estimate8.13
Beta2.04
EPS (TTM)-0.86
Dividend per share-
Ex-div date-
Next earnings date5 Nov 2025

Downside potential

Loading...
Downside potential data
ABSIS&P500
Current price drop from All-time high-90.79%-3.04%
Highest price drop-96.20%-56.47%
Date of highest drop26 Oct 20239 Mar 2009
Avg drop from high-83.73%-11.04%
Avg time to new high140 days12 days
Max time to new high975 days1805 days
COMPANY DETAILS
ABSI (Absci Corp) company logo
Marketcap
417.17M
Marketcap category
Small-cap
Description
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, and Owkin for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Employees
156
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...